Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Endometrial Neoplasms 5Endometrial Hyperplasia 3Polycystic Ovary Syndrome 2Obesity 2Leiomyoma 2Infertility 2Overweight 1Ovarian Neoplasms 1Osteoporosis 1Neoplasms 1Myocardial Ischemia 1Heart Diseases 1Gliosarcoma 1Glioblastoma 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1Bone Diseases 1Anovulation 1

Interventions

Zoledronic Acid 16Risedronic Acid 9Vitamin D 8Calcium 8Letrozole 6Cholecalciferol 5Calcium Carbonate 5Alendronate 5Denosumab 4Absorptiometry, Photon 4Calcium Gluconate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Progesterone 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Goserelin 2Estradiol 2Calcium Citrate 2xian ling gu bao 1romosozumab 1X-Rays 1Toremifene 1Testosterone 1Technetium 1Spectrum Analysis 1Raloxifene Hydrochloride 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Osteoporosis × Progestins × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡